Olivier Colomban

7PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 07, 2025
Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO Study.

Aurore Carrot, Pauline Corbaux, Olivier Colomban

|Jun 17, 2024
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer.

Pauline Corbaux, Olivier Colomban, Aurore Carrot

|Apr 19, 2023
Benefit From Fractionated Dose-Dense Chemotherapy in Patients With Poor Prognostic Ovarian Cancer: ICON-8 Trial.

Olivier Colomban, Andrew Clamp, Adrian Cook

|Apr 01, 2022
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era.

Benoit You, Lilian Van Wagensveld, Michel Tod

Pageof 2